Alkermes plc

NASDAQ:ALKS  
22.23
-0.01 (-0.04%)
Products, Litigation

Alkermes Files Lawsuit Against Teva USA & Teva Pharmaceutical Industries

Published: 09/09/2020 21:36 GMT
Alkermes plc (ALKS) - Alkermes Plc - Co's Units Filed Patent Infringement Lawsuit in U.S. District Court Against Teva USA & Teva Pharmaceutical Industries Ltd.
Alkermes - Lawsuit Filed in Response to Teva USA’s Notice Letter Regarding Anda Submitted Related to Generic Version of Vivitrol in U.S.alkermes - Teva USA's Notice Letter Alleges ’499 Patent is Invalid, Unenforceable And/or Will Not Be Infringed by Teva USA’s Proposed Product.
Alkermes - Teva USA's Notice Letter Referenced Paragraph Iv Certification Against One Alkermes Patent Related to Vivitrol ('499 Patent).